gentamicin has been researched along with hr 810 in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 10 (58.82) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
Spencer, RC; Wheat, PF | 1 |
Baltch, AL; Franke, M; Michelsen, P; Ritz, WJ; Singh, J; Smith, RP; Valdes, JM; Williams, S | 1 |
Hubrechts, JM; Nulens, E; Nyssen, HJ; Roebben, E; Vanhoof, R | 1 |
Boothman, C; King, A; Phillips, I | 1 |
Bartmann, K; Tarbuc, R | 1 |
Chin, NX; Neu, HC; Novelli, A | 1 |
Murray, PR; Niles, AC | 1 |
Braveny, I; Machka, K | 1 |
Klesel, N; Limbert, M; Seibert, G | 1 |
Brandt, CM; Rouse, MS; Steckelberg, JM; Tallan, BM; Wilson, WR | 1 |
Coulthard, M; Ehrett, S; Friedland, IR; Jafari, H; McCracken, GH; Olsen, K; Paris, M; Rinderknecht, S; Saxen, H | 1 |
Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Aubert, G; Carricajo, A; Vermesch, R | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
17 other study(ies) available for gentamicin and hr 810
Article | Year |
---|---|
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
In vitro activity of cefpirome (HR810) against Enterococcus species.
Topics: Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus | 1990 |
Comparative therapy with cefpirome alone and in combination with rifampin and/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice.
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Kidney; Leukopenia; Liver; Lung; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Spleen | 1990 |
[Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Cephalothin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; In Vitro Techniques; Quinolones | 1990 |
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests | 1990 |
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines | 1985 |
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Streptococcus | 1986 |
In vitro activity of HR 810, a new broad-spectrum cephalosporin.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Humans; Neisseriaceae; Penicillin Resistance; Piperacillin; Staphylococcus aureus | 1983 |
Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Kanamycin | 1984 |
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
Topics: Animals; Cefazolin; Cefpirome; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Predictive Value of Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1994 |
Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Chloramphenicol; Endotoxins; Escherichia coli Infections; Gentamicins; Inflammation; Male; Meningitis, Bacterial; Meropenem; Rabbits; Thienamycins | 1993 |
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1998 |
In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |